Published in J Neurol Neurosurg Psychiatry on July 01, 1997
Genetics of cerebral cavernous malformations: current status and future prospects. J Neurosurg Sci (2015) 0.76
Familial cavernous angiomas masquerading as multiple sclerosis. Postgrad Med J (1998) 0.75
Varying clinical presentations of familial cerebral cavernous malformations (CCMs) and spinal cord cavernous malformations (SCCMs). Radiol Case Rep (2015) 0.75
Multilocus linkage analysis in humans: detection of linkage and estimation of recombination. Am J Hum Genet (1985) 87.59
A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature (1996) 27.61
A second-generation linkage map of the human genome. Nature (1992) 16.32
The natural history of familial cavernous malformations: results of an ongoing study. J Neurosurg (1994) 3.06
Natural history of the cavernous angioma. J Neurosurg (1991) 3.02
An analysis of the natural history of cavernous angiomas. J Neurosurg (1991) 2.97
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nat Genet (1993) 2.79
Cerebral cavernous malformations. Incidence and familial occurrence. N Engl J Med (1988) 2.65
[131 cases of cavernous angioma (cavernomas) of the CNS, discovered by retrospective analysis of 24,535 autopsies]. Neurochirurgie (1989) 2.10
The MRI appearance of cavernous malformations (angiomas). J Neurosurg (1987) 1.93
A gene responsible for cavernous malformations of the brain maps to chromosome 7q. Hum Mol Genet (1995) 1.74
Natural history of intracranial cavernous malformations. J Neurosurg (1995) 1.64
Cavernous angioma: a review of 126 collected and 12 new clinical cases. Neurosurgery (1986) 1.53
Mapping a gene causing cerebral cavernous malformation to 7q11.2-q21. Proc Natl Acad Sci U S A (1995) 1.43
A founder mutation as a cause of cerebral cavernous malformation in Hispanic Americans. N Engl J Med (1996) 1.28
Cerebral cavernous haemangiomas or cavernomas. Incidence, pathology, localization, diagnosis, clinical features and treatment. Review of the literature and report of an unusual case. Neurochirurgia (Stuttg) (1976) 1.25
Cavernomas of the central nervous system: clinical and neuroimaging manifestations in 47 patients. J Neurol Neurosurg Psychiatry (1991) 1.17
A locus for cerebral cavernous malformations maps to chromosome 7q in two families. Genomics (1995) 1.15
Factors predisposing to clinical disability in patients with cavernous malformations of the brain. Neurosurgery (1993) 1.09
Cavernous angiomas of the central nervous system in children. J Neurosurg (1992) 1.07
Cavernous malformations of the brain stem. J Neurosurg (1991) 1.02
Familial cavernous angiomas: natural history and genetic study over a 5-year period. Am J Med Genet (1982) 1.01
Familial cerebral cavernous angiomas: clinical and radiologic studies. Neurology (1995) 0.99
Familial cavernous angiomas of the brain: observations in a four generation family. Eur J Pediatr (1992) 0.95
Refined localization of the cerebral cavernous malformation gene (CCM1) to a 4-cM interval of chromosome 7q contained in a well-defined YAC contig. Genome Res (1995) 0.94
Genetic heterogeneity of inherited cerebral cavernous malformation. Neurosurgery (1996) 0.94
Cerebral cavernous malformations (cavernomas) in the pediatric age-group. Childs Nerv Syst (1991) 0.89
Familial cerebral cavernous angioma: a gene localized to a 15-cM interval on chromosome 7q. Ann Neurol (1996) 0.88
Familial cavernous angiomas of the brain in an Hispanic family. Neurology (1988) 0.85
Spinal cord cavernous malformation in a patient with familial intracranial cavernous malformations. Neurosurgery (1990) 0.84
Indications for surgery and prognosis in patients with cerebral cavernous angiomas. Neurol Med Chir (Tokyo) (1992) 0.81
The surgery of cavernomas both supra-tentorial and infra-tentorial. Adv Tech Stand Neurosurg (1995) 0.80
Familial cavernous malformations of the central nervous system and retina. Ann Neurol (1987) 0.80
Progressive vision loss. A rare manifestation of familial cavernous angiomas. Arch Neurol (1992) 0.80
[Neuropathologic study of cavernomas]. Neurochirurgie (1989) 0.77
[Intracranial cavernous angioma]. Rev Neurol (Paris) (1992) 0.77
Cerebral cavernous angioma. Diagnostic considerations. J Neuroradiol (1993) 0.77
Cavernous angiomatosis of the central nervous system: usefulness of screening the family. Acta Neurol Scand (1993) 0.77
Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature (1996) 8.02
A missense mutation in the alphaB-crystallin chaperone gene causes a desmin-related myopathy. Nat Genet (1998) 4.75
Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn (2010) 4.48
Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet (1997) 3.68
Clinical spectrum of CADASIL: a study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Lancet (1995) 3.42
The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J Clin Invest (2000) 3.02
Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas. Nat Genet (1999) 2.79
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nat Genet (1993) 2.79
The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N Engl J Med (2001) 2.70
Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations. Am J Hum Genet (2004) 2.62
Bruxism physiology and pathology: an overview for clinicians. J Oral Rehabil (2008) 2.42
Dysembryoplastic neuroepithelial tumor: a surgically curable tumor of young patients with intractable partial seizures. Report of thirty-nine cases. Neurosurgery (1988) 2.41
HLA B*44: protective effects in MS susceptibility and MRI outcome measures. Neurology (2010) 2.29
Diagnostic value of endoscopic capsule in patients with obscure digestive bleeding: blinded comparison with video push-enteroscopy. Endoscopy (2003) 2.20
Benign notochordal cell tumour: case report. Diagn Interv Imaging (2013) 1.99
Mutations within the MGC4607 gene cause cerebral cavernous malformations. Am J Hum Genet (2004) 1.88
The Hox-1.3 homeo box protein is a sequence-specific DNA-binding phosphoprotein. Genes Dev (1989) 1.83
A gene for hereditary paroxysmal cerebellar ataxia maps to chromosome 19p. Ann Neurol (1995) 1.74
Paul Broca's historic cases: high resolution MR imaging of the brains of Leborgne and Lelong. Brain (2007) 1.72
Clinical and brain MRI follow-up study of a family with COL4A1 mutation. Neurology (2007) 1.71
Poly(ADP-ribose) polymerase alleles in French Caucasians are associated neither with lupus nor with primary antiphospholipid syndrome. GRAID Research Group. Group for Research on Auto-Immune Disorders. Arthritis Rheum (1999) 1.67
The structural components of music perception. A functional anatomical study. Brain (1997) 1.66
Autosomal dominant leukoencephalopathy and subcortical ischemic stroke. A clinicopathological study. Stroke (1993) 1.65
Regional cerebral oxygen consumption, blood flow, and blood volume in healthy human aging. Arch Neurol (1992) 1.60
Saccular intracranial aneurysms: endovascular treatment with mechanical detachable spiral coils. Radiology (1997) 1.59
Pediatric cerebral aneurysms. J Neurosurg (2001) 1.57
Notch signalling pathway and human diseases. Semin Cell Dev Biol (1998) 1.52
Thrombotic cocktail in stroke. Neurology (2005) 1.51
The in vivo metabolic pattern of low-grade brain gliomas: a positron emission tomographic study using 18F-fluorodeoxyglucose and 11C-L-methylmethionine. Neurosurgery (1997) 1.50
Hereditary infantile hemiparesis, retinal arteriolar tortuosity, and leukoencephalopathy. Neurology (2003) 1.50
The neural substrates of memory systems impairment in Alzheimer's disease. A PET study of resting brain glucose utilization. Brain (1998) 1.49
Skin biopsy immunostaining with a Notch3 monoclonal antibody for CADASIL diagnosis. Lancet (2001) 1.47
Sporadic late onset paroxysmal cerebellar ataxia in four unrelated patients: a new disease? J Neurol (2001) 1.45
Missense CACNA1A mutation causing episodic ataxia type 2. Arch Neurol (2001) 1.44
Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria. J Neurol Neurosurg Psychiatry (1997) 1.44
Intracranial dural fistula as a cause of diffuse MR enhancement of the cervical spinal cord. J Neurol Neurosurg Psychiatry (1999) 1.44
Patterns of MRI lesions in CADASIL. Neurology (1998) 1.43
Ischaemia of the hand after radial artery monitoring. Cardiovasc Surg (1996) 1.43
Clinical severity in CADASIL related to ultrastructural damage in white matter: in vivo study with diffusion tensor MRI. Stroke (1999) 1.41
[CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy)]. J Mal Vasc (1996) 1.40
Evaluation and treatment of lower urinary tract symptoms in older men. J Urol (2009) 1.40
[Detection of cortical activities on eye movement using functional magnetic resonance imaging]. Nippon Ganka Gakkai Zasshi (1997) 1.39
Plasma superoxide dismutase and glutathione peroxidase activity in sporadic amyotrophic lateral sclerosis. J Neurol Sci (1997) 1.39
Single vital capacity breath for preoxygenation. Can J Anaesth (2000) 1.38
[Albert Gombault (1844-1904). A pioneer of neuroscience]. Rev Neurol (Paris) (2006) 1.38
De novo mutation in the Notch3 gene causing CADASIL. Ann Neurol (2000) 1.36
Diagnosis and treatment of dural carotid-cavernous fistulas: a consecutive series of 27 patients. J Neurol Neurosurg Psychiatry (2006) 1.33
Kinetics of expression of costimulatory molecules and their ligands in murine relapsing experimental autoimmune encephalomyelitis in vivo. J Immunol (1998) 1.32
Restricted T-cell receptor V beta gene usage by myelin basic protein-specific T-cell clones in multiple sclerosis: predominant genes vary in individuals. Proc Natl Acad Sci U S A (1991) 1.31
Oligodendrogliomas. Part I: Patterns of growth, histological diagnosis, clinical and imaging correlations: a study of 153 cases. J Neurooncol (1997) 1.31
Cerebral hemodynamics in CADASIL before and after acetazolamide challenge assessed with MRI bolus tracking. Stroke (2000) 1.29
New triple coaxial catheter system for carotid angioplasty with cerebral protection. AJNR Am J Neuroradiol (1990) 1.29
Autosomal dominant syndrome with strokelike episodes and leukoencephalopathy. Stroke (1991) 1.28
Hemispheric disconnection syndrome with a "crossed avoiding" reaction in a case of Marchiafava-Bignami disease. J Neurol Neurosurg Psychiatry (1977) 1.27
Krit1/cerebral cavernous malformation 1 mRNA is preferentially expressed in neurons and epithelial cells in embryo and adult. Mech Dev (2002) 1.27
Short-chain fructo-oligosaccharide administration dose-dependently increases fecal bifidobacteria in healthy humans. J Nutr (1999) 1.26
Chronic myelopathies associated with human T-lymphotropic virus type I. A clinical, serologic, and immunovirologic study of ten patients in France. Arch Neurol (1989) 1.26
Hereditary cerebral cavernous angiomas: clinical and genetic features in 57 French families. Société Française de Neurochirurgie. Lancet (1998) 1.25
Clinical impact of capsule endoscopy compared to push enteroscopy: 1-year follow-up study. Endoscopy (2005) 1.22
De novo mutations in ATP1A2 and CACNA1A are frequent in early-onset sporadic hemiplegic migraine. Neurology (2010) 1.20
[Letter: Toxic polyneuritis in a plastic worker. Possible role of methyl-ethyl-ketone]. Nouv Presse Med (1975) 1.20
Stereoelectroencephalography in focal cortical dysplasia: a 3D approach to delineating the dysplastic cortex. Brain (2000) 1.17
Supraselective embolization in intractable epistaxis: review of 45 cases. Laryngoscope (1998) 1.16
[Linear or bubbly: a pictorial review of CT features of intestinal pneumatosis in adults]. J Radiol (2008) 1.16
H3-receptors control histamine release in human brain. J Neurochem (1988) 1.15
Evaluation and treatment of lower urinary tract symptoms in older men. J Urol (2013) 1.13
Mutations in the muscle sodium channel gene (SCN4A) in 13 French families with hyperkalemic periodic paralysis and paramyotonia congenita: phenotype to genotype correlations and demonstration of the predominance of two mutations. Eur J Hum Genet (1994) 1.12
Dysembryoplastic neuroepithelial tumors: nonspecific histological forms -- a study of 40 cases. J Neurooncol (1999) 1.12
High prevalence of CACNA1A truncations and broader clinical spectrum in episodic ataxia type 2. Neurology (1999) 1.09
The natural history of familial cerebral cavernomas: a retrospective MRI study of 40 patients. Neuroradiology (2000) 1.09
Diffusion tensor imaging study of subcortical gray matter in cadasil. Stroke (2001) 1.08
Functional connectivity of the human red nucleus in the brain resting state at 3T. AJNR Am J Neuroradiol (2008) 1.08
Gonadotropin-releasing hormone differentially regulates expression of the genes for luteinizing hormone alpha and beta subunits in male rats. Proc Natl Acad Sci U S A (1986) 1.08
Accuracy of computed tomographic colonography in a nationwide multicentre trial, and its relation to radiologist expertise. Gut (2011) 1.08
Cognitive profile in CADASIL. J Neurol Neurosurg Psychiatry (2006) 1.08
Angioarchitecture associated with haemorrhage in cerebral arteriovenous malformations: a prognostic statistical model. Neuroradiology (1997) 1.07
Clinical and spectroscopic improvement in HIV-associated cognitive impairment. Neurology (2001) 1.07
Presence of ultrastructural arterial lesions in muscle and skin vessels of patients with CADASIL. Stroke (1994) 1.06
T cell response to myelin basic protein epitopes in multiple sclerosis patients and healthy subjects. Eur J Immunol (1991) 1.06